NSE
Mankind Pharma LimitedMANKIND
Mankind Pharma is a fast-growing domestic-focused pharma & consumer-health company.
| Key products | Branded generics and consumer products (Manforce, Prega News, Gas-O-Fast). |
|---|---|
| Geography | India. |
| Competitors | Sun Pharma, Alkem, Cipla. |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹445.9 Cr
Institutional buyers
19 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
Interim Dividend - Re 1 Per Share
ex 2025-08-08
Competitive landscape — the read
vs mapped peers| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | CIPLA | +₹1,527.1 Cr | 39 | — | +1 | +10 | 34 |
| 2 | MANKINDThis | +₹445.9 Cr | 38 | — | — | — | — |
| 3 | ALKEM | +₹103.5 Cr | 33 | — | — | -2 | 6 |
| 4 | DRREDDY | +₹0 Cr | 4 | — | — | +15 | 32 |
| 5 | SUNPHARMA | +₹0 Cr | 6 | — | +2 | +9 | 29 |
| 6 | TORNTPHARM | +₹0 Cr | 2 | — | — | — | — |
| 7 | LUPIN | +₹0 Cr | 4 | — | — | — | — |
| 8 | ZYDUSLIFE | +₹0 Cr | 1 | — | — | — | — |
| 9 | AUROPHARMA | +₹0 Cr | 2 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — MANKIND day by day
- 2026-06-15FilingMankind Pharma Limited has informed the Exchange about Schedule of meetInvestor Call
- 2026-06-10Filing Ramesh Juneja has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities andShareholding Disclosure
- 2026-06-08FilingMankind Pharma Limited has informed the Exchange regarding Cessation of Mr Prateek Dubey as SMP of the companyManagement
- 2026-06-08FilingMankind Pharma Limited has informed the Exchange regarding Appointment of Mr Nilesh Kulkarni as SMP of the comManagement
- 2026-06-08FilingMankind Pharma Limited has informed the Exchange regarding allotment of 86778 securities pursuant to ESOP/ESPSAllotment of Securities
- 2025-10-14BlockSELL · ₹13.4 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-10-14BlockBUY · ₹13.4 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-10-13BlockSELL · ₹10.3 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-10-13BlockBUY · ₹10.3 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-08-08ActionInterim Dividend - Re 1 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 4
- 4
- 2Allotment of SecuritiesNeutral
allotment of 86778 securities pursuant to ESOP/ESPS at its meeting held on Jun 08, 2026
Source PDF →
4 deals · 2025-10-13 → 2025-10-14
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2025-10-14 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹13.4 Cr |
| 2025-10-14 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹13.4 Cr |
| 2025-10-13 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹10.3 Cr |
| 2025-10-13 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹10.3 Cr |
4 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
News & chatter on MANKIND
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.